From the Department of Medicine, Cardeza Foundation
for Hematologic Research, Jefferson Medical College, Philadelphia,
Pennsylvania 19041, the § Department of Clinical and
Laboratory Medicine, Yamanashi Medical University, Yamanashi 409-3898, Japan, and the
Department of Clinical Pharmaceutical Science,
Graduate School of Medicine, Hiroshima University, Hiroshima 734-8551, Japan
Received for publication, September 11, 2002, and in revised form, December 6, 2002
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Human filamins are 280-kDa proteins containing an
N-terminal actin-binding domain followed by 24 characteristic repeats.
They also interact with a number of other cellular proteins. All of those identified to date, with the exception of actin, bind to the
C-terminal third of a filamin. In a yeast two-hybrid search of a human
placental library, using as bait repeats 10-18 of filamin B, we
isolated a cDNA coding for a novel 374 amino acid protein containing a proline-rich domain near its N terminus and two LIM domains at its C terminus. We term this protein filamin-binding LIM
protein-1, FBLP-1. Yeast two-hybrid studies with deletion mutants
localized the areas of interaction in FBLP-1 to its N-terminal domain
and in filamin B to repeats 10-13. FBLP-1 mRNA was detected in a
variety of tissues and cells including platelets and endothelial cells.
We also have identified two FBLP-1 variants. Both contain three
C-terminal LIM domains, but one lacks the N-terminal proline-rich domain. Transfection of FBLP-1 into 293A cells promoted stress fiber
formation, and both FBLP-1 and filamin B localized to stress fibers in
the transfected cells. The association between filamin B and FBLP-1 may
play a hitherto unknown role in cytoskeletal function, cell adhesion,
and cell motility.
The human filamin (FLN)1
family consists of three ~280-kDa actin-binding paralogs (FLNs A, B,
and C), each containing an N-terminal actin-binding domain followed by
24 characteristic ~96 residue Current data suggest that FLNs may have multiple functions. 1) They are
involved in the organization of the cytoskeleton (4, 5) and appear to
be necessary for normal cell adhesion and motility (6). 2) They bind to
the cytoplasmic tails of a number of membrane proteins including
several Most interactions with FLNs have been identified as a result of yeast
two-hybrid studies using as bait a variety of membrane or cytoplasmic
proteins. In this manner, one or another filamin has been identified as
an interactant with some 25 proteins (2, 15-19). In every case where
localization studies have been performed, the interaction site on the
filamin has been in the C-terminal third of the molecule. Because the
libraries that were screened tend to be relatively enriched in
3'-sequences, it seemed possible that interactions with the more
N-terminal portions of the filamins might have been missed.
Accordingly, we embarked on a yeast two-hybrid search using as bait
FLNB repeats 10-18. We report here the identification and
characterization of a new member of the LIM protein superfamily, filamin-binding LIM protein-1 (FBLP-1), that interacts with FLNB proximal to the binding site of all of the other known filamin interactants with the exception of actin. The interaction between FLNB
and FBLP-1 may play an important role in actin cytoskeleton organization.
Two-hybrid Library Screening and Full-length cDNA
Cloning--
During the cloning of full-length FLNB, we had previously
isolated from a human placental cDNA library a cDNA fragment
(Fig. 5, construct 1) designated FLNB-(10-18), which
codes for repeats 10-18 (residues 1128-1956) of FLNB but lacks the
first hinge domain (residues 1704-1727) because of alternative
splicing. FLNB-(10-18) was directionally cloned into the yeast
expression vector pGBKT7 (Clontech, Palo Alto, CA).
This construct expresses a fusion protein consisting of repeats 10-18
of FLNB and the yeast GAL4 DNA-binding domain.
A yeast two-hybrid human placental cDNA library (in pACT2,
Clontech) was screened. Yeast strain AH109 was
transformed sequentially with the FLNB-(10-18) vector and the library
vectors. Transformants were plated on
SD/Trp
To obtain the remaining 5' end of the cDNA, double-stranded
cDNA was synthesized from human placental poly(A)+ RNA
and subjected to 5'-RACE using a Marathon cDNA amplification kit
(Clontech). After ligating the Marathon adaptor to
the 5' ends of the double-stranded cDNA, two-step (nested) PCR
amplification was performed using two adaptor primers and two
gene-specific primers: FP4, 5'-ACAAACTGCCTGCCTCAC-3', and FP4-in,
5'-ACTTCCTCCGCCACGGCCACATC-3'. A 600-bp PCR product was extracted from
agarose gel, transferred to pT7BLUE (Novagen, Madison, WI), and
sequenced. Isolated cDNA inserts were transferred to the sequencing
vector pBluescript (Stratagene, La Jolla, CA), and both strands were
sequenced using universal primers or synthetic oligonucleotides.
Sequencing was performed using Dyedeoxy Terminator Cycle Sequencing
kits and a model 377 or 310 DNA-sequencing system (Applied Biosystems, Foster City, CA).
DNA Constructs--
The fragment of FLNB (Fig. 5,
constructs 2-6) were excised from cDNA clones in
pBluescript by restriction enzymes and introduced into pGBKT7. An
expressed sequence tag clone AK027444, which contains the
full-length cDNA of FBLP-1B, was purchased from the Helix Research
Institute (Chiba, Japan). The various constructs in Fig. 5B
were prepared by restriction enzymes using FPC1-22 and AK027444 and
introduced into pACT2. A full-length FLNB construct was assembled in
pBluescript from overlapping FLNB cDNA clones by standard methods
and transferred into pcDNA3.1/Zeo. The full-length human zyxin
cDNA in pCMV-Sport6 (IMAGE 3904696) was purchased from the IMAGE
consortium. The GFP fusion protein expression constructs were prepared
by transferring the full-length cDNA of FBLP-1 or zyxin into
pEGFP-C1 (Clontech).
Tissue and Cellular Distribution of FBLP-1 and Its
Variants--
To analyze the tissue and cell distribution of each
variant of FBLP-1, cDNA from various tissues
(Clontech) and cells was used as template for PCR
amplification. Oligonucleotides used were as follows: FP3,
5'-TACCAGGACACACTGGAG-3'; FP7, 5'-GTGCACAAACCCTTCTC G-3'; FP8,
5'-GTTCACGCCATTCTCCTG-3'; and FP9, 5'-AGAGCAGGTTAGGAAGGG-3'. Southern
blotting of PCR products was performed using the 1.3-kilobase insert of
the FPC1-22 clone as a probe and the ECL detecting system (Amersham
Biosciences).
Antibodies--
A glutathione S-transferase-FLNB
fusion protein expression vector was constructed by subcloning a FLNB
cDNA coding repeats 14-24 (residues 1519-2602), including the
first hinge, into pGEX-5X-3 (Amersham Biosciences). A rabbit polyclonal
antibody was prepared by immunizing with the fusion protein. IgG was
purified by protein G-Sepharose, the anti-glutathione
S-transferase fraction was removed on a glutathione
S-transferase-Sepharose column, and specific IgG was
purified by passage over a column of fusion protein coupled to Sepharose.
Mammalian Transfection and Immunoprecipitation--
As a
transfection control, we used the GFP expression vector pEGFP-N1
(Clontech) without any insert. Transient
transfection of human fibroblast 293 cells was performed using the
calcium phosphate method. Transfected cells were detached by 0.5 M EDTA-PBS, washed with PBS, and lysed in radioimmune
precipitation assay buffer (1% Triton X-100, 0.5% deoxycholate, 0.1%
SDS, 150 mM NaCl, 30 mM Tris-HCL, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, pH7.5) on ice for 15 min. After centrifugation at
15,000 for 10 min, lysates were pre-cleared by incubation with protein
G-agarose (Pierce) at room temperature for 90 min. Polyclonal anti-FLNB-(14-24) or polyclonal anti-GFP
(Clontech) was incubated with protein G-agarose for
90 min at room temperature and washed five times with Tris-buffered
saline. The pre-cleared lysates were mixed with the antibody-agarose
complexes and incubated overnight at 4 °C. Immunoprecipitates were
washed five times in Triton X-100 buffer and boiled in SDS-PAGE sample
buffer. Each sample was separated on 5 or 7.5% SDS-PAGE, transferred
to a polyvinylidene difluoride membrane, and incubated with
anti-FLNB-(14-24) or monoclonal anti-GFP (Medical & Biological
Laboratories, Nagoya, Japan). Antibody binding was detected using
peroxidase-conjugated secondary antibodies and was visualized with the
ECL reagent (Amersham Biosciences).
Immunohistochemistry--
The 293A cell line we used, a subclone
of the 293 cell line, was kindly provided by Dr. Jeffrey Benovic
(Kimmel Cancer Institute, Jefferson Medical College). This subclone has
greater adhesive and spreading ability than the parental 293 cells.
Transient transfection was performed using Effectene reagent (Qiagen).
After transfection, fixed and permeabilized cells were incubated with
3% bovine serum albumin-PBS for 30 min at room temperature and then
incubated with anti-FLNB-(14-24), anti-FLNA monoclonal antibodies TI10
and PM6/317 (Biodesign, Saco, ME), or the anti-vinculin monoclonal antibody hVIN-1 (Sigma). After washing with 0.1% bovine serum albumin-PBS and further incubation with 3% bovine serum albumin-PBS, the cells were incubated with Cy3-labeled goat anti-rabbit or anti-mouse IgG (Sigma). Other cells not incubated with antibodies were
incubated with TRITC-labeled phalloidin (Sigma). Stained cells were
visualized by inverted fluorescence microscopy (Olympus, Tokyo, Japan).
Isolation of FBLP-1--
Using as bait FLNB-(10-18), we screened
2 × 105 clones of a human placental two-hybrid
library and isolated seven positives. To eliminate false-positives, we
re-introduced these clones into yeast together with either the
FLNB-(10-18) bait or pLAM5'. Six clones showed trans-activation of
HIS3, ADE2, and LacZ in the presence of the FLNB bait. However, five of
the six also interacted with the lamin bait and were considered
nonspecific. The sixth clone, FPC1-22, which reacted specifically with
FLNB-(10-18), contained a 1.3-kilobase insert terminating in a poly(A)
sequence and was sequenced.
As shown in Fig. 1, the sequence of
FPC1-22 predicts a polypeptide consisting of 374 amino acids. Since
upon sequencing, no in-frame termination codon was found upstream of
the putative first ATG codon, we performed 5'-RACE, using human
placental poly(A)+ RNA and identified an in-frame stop
codon 72 bp upstream of this ATG. Thus, this ATG was designated as the
initiation codon. We term this protein human FBLP-1
(filamin-binding LIM
protein-1 (GenBankTM accession number AF459643)). FBLP-1
has a proline-rich domain near its N terminus, two LIM domains, and a
unique ~70 amino acid sequence at its C terminus. As shown in Fig.
2, the structure of FBLP-1 is similar to
that of the zyxin family of proteins (zyxin, LPP, and trip6) and more
weakly homologous to other LIM family members (paxillin, hic-5, and
leupaxin). FBLP-1 has two (F/L)PPPP motifs in its proline-rich
domain. In other LIM family members, these motifs serve as a ligand for
a subset of Ena-VASP homology 1 domain proteins. FBLP-1 also contains a leucine-rich nuclear export signal as indicated in Fig. 1. This nuclear
export signal motif (LXXXLXXL) is also
present in zyxin family members and is thought to play a role in
nuclear-cytoplasmic trafficking.
Using the BLAST program to search the GenBank data base, we identified
two closely related full-length cDNAs (GenBankTM
accession numbers AK055259 and AK027444) coding for hypothetical proteins (Fig. 3). Both predicted
proteins have three C-terminal LIM domains, whereas AK027444 lacks a
proline-rich domain. In this paper, we refer to AK055259 and AK027444
as FBLP-1A and FBLP-1B, respectively.
By searching the data base, we found a genomic DNA sequence
(GenBankTM accession number AL450998) from bacterial
contigs of human chromosome 1 that contains the sequence of FBLP-1. On
the basis of this sequence, the exon-intron organization of the
FBLP-1 gene can be depicted as shown in Fig. 3. The
proline-rich domain of FBLP-1 is a product of exons 3 and 4, the first
and second LIM domains are produced by exons 5 and 6a, and the
C-terminal unique sequence is produced by exon 6b. A consensus sequence
for alternative splicing is present at the junction of exons 6a and 6b.
Exon 6b is spliced out in FBLP-1A and FBLP-1B. The additional LIM
domain of these two variants is coded by exon 7. Exons 3 and 4 are
spliced out in FBLP-1B, resulting in the deletion of the proline- rich domain.
During this analysis, we observed that an STS marker, WI-14085,
was part of the gene. This marker has been linked to microsatellite marker D1S3543 in 1p36.13. These data have been grouped as UNIGENE Hs.8728, UniSTS SHGC-13447, and LocusLink 54751.
Verification of the Interaction Between FLNB and FBLP-1--
To confirm the interaction between FLNB and FBLP-1 at the
protein level, we transiently co-transfected 293A cells with
full-length FLNB and either GFP or GFP-FBLP-1. After 48 h, cells
were lysed with radioimmune precipitation assay buffer and
immunoprecipitated with anti-GFP IgG. Western blotting was performed
with anti-GFP or anti-FLNB-(14-24) IgG (Fig.
4). The anti-GFP IgG precipitated equally
GFP alone and GFP-FBLP-1; however, FLNB was detected only in
precipitates from the GFP-FBLP-1 co-transfectants. A large amount of
FLNB was still present in the supernatant after immunoprecipitation. We
also performed the reverse immunoprecipitation using anti-FLNB IgG and
detecting with anti-GFP IgG; however GFP-FBLP-1 was not detected in the
immunoprecipitate (data not shown). These data suggest that only a
small fraction of FLNB is associated with FBLP-1, although most of the
FBLP-1 is associated with FLNB.
Localization of the Interacting Domains of FLNB and
FBLP-1--
To identify the domain interacting with FBLP-1, each
of several subdomains of FLNB was introduced into yeast together with FPC1-22, and X-
To identify the domain of FBLP-1 interacting with FLNB, each of the
FBLP-1 constructs shown in Fig. 5B was introduced into yeast
together with FLNB-(10-18) in pGBKT-7. As shown in the figure, the
N-terminal 70 amino acid sequence (before the proline-rich domain)
contains the filamin-binding domain. Yeast transformed with
FLNB-(10-18) and FBLP-1A or FBLP-1B were slow-growing and produced
small colonies on plates, although both were positive in the X- Tissue and Cellular mRNA Expression of FBLP-1 and
Variants--
Using primers FP3 and FP7, a 206-bp fragment of FBLP-1
was amplified (Fig. 6, upper
panel). Primers FP3 and FP8 amplified a 531-bp fragment of FBLP-1;
however, some extra products were observed (data not shown). Primers
FP3 and FP9 designed to amplify the common region of FBLP-1A and
FBLP-1B amplified a 498-bp fragment from both FBLP-1A and FBLP-1B (Fig.
6, lower panel). FBLP-1 was detected in most tissues tested
with the except of liver; however, FBLP-1A and FBLP-1B could not be
detected in brain, liver, or skeletal muscle. FBLP-1 was detected both
in platelets and the megakaryocyte-like cell line, CMK, although
FBLP-1A and FBLP-1B were detected only in platelets.
Intracellular Localization of FBLP-1--
To evaluate the cellular
localization of FBLP-1, 293A cells were transfected with GFP-FBLP-1 and
plated on uncoated plastic culture dishes (Fig.
7). Although 293A cells spread more
readily than the parental 293 cell line, 293A cells demonstrate limited numbers of stress fibers when grown on uncoated plastic culture dishes.
The overexpression of FBLP-1 markedly increased stress fiber formation
(Fig. 7, A-F versus I). Furthermore,
both FLNB and FBLP-1 are localized to stress fibers in the transfected
cell (Fig. 7, A-C, left). In contrast, FLNB is
distributed diffusely throughout the cytoplasm in the non-transfected
cell (Fig. 7C, right). FBLP-1 co-localized with
F-actin stained by phalloidin (Fig. 7H) on stress fibers. In
the GFP-transfected control, GFP was present diffusely throughout the
nucleus and cytoplasm (Fig. 7, I and J). These
results strongly suggest that FBLP-1 may dynamically support the
reorganization of stress fibers. FLNA also co-localized with FBLP-1 to
stress fibers (Fig. 7, D-F). Although we have not examined
directly the interaction of FBLP-1 and FLNA, this observation suggests
that such an interaction occurs.
To compare the localization pattern of FBLP-1 with zyxin, 293A cells
grown on gelatin-coated plates were transfected with GFP-FBLP-1 or
GFP-zyxin. As shown in Fig. 8, GFP-FBLP-1
(green color) strongly localized to stress fibers (Fig. 8,
A, C, and E) but not to filopodia
(solid arrowheads) or lamellipodia (open arrowhead). On the other hand, GFP-zyxin localized at focal
adhesions and at filopodia and lamellipodia (Fig. 8F,
orange) but not on stress fibers (Fig. 8, B,
D, and F). Because other members of the zyxin
family have been reported to localize at focal adhesion plaques,
GFP-FBLP-1-transfected cells were stained with anti-vinculin antibody
to identify focal adhesion plaques (Fig.
9). Although weak signals were detected
at focal adhesions, GFP-FBLP-1 localized preferentially to stress
fibers. Vinculin, on the other hand, localized largely to focal
adhesions in the transfected cells.
Filamins are represented in almost all living species, usually as
a small family of paralogs. As already mentioned, filamins are involved
in the organization of the cytoskeleton and appear to be necessary for
normal cell adhesion and motility. Furthermore, they bind to the
cytoplasmic tails of a growing number of membrane proteins, suggesting
that they play a role in cytoskeletal-membrane interactions. In
addition, they bind several cytoplasmic components of signaling
pathways and may serve as a point of convergence for signals between
the cell membrane and the cell interior.
Filamin A (ABP-280) and chicken gizzard filamin were the first members
of the superfamily to be identified and were originally characterized
as proteins that promote actin filament bundling in F-actin solutions.
FLNA appears to promote orthogonal actin filament organization (5),
whereas chicken gizzard filamin appears to induce parallel bundling of
actin filaments (20). Flanagan et al. (21) demonstrated that
in cells expressing FLNA, this protein plays an essential role in the
stabilization of orthogonal actin networks required for locomotion.
Recently, we reported (8) that a splice variant of FLNB interacts with
the cytoplasmic domain of the integrins Actin cytoskeleton organization is orchestrated both by polymerization
of actin monomers and by cross-linking of the resultant actin
filaments. The bacterial pathogen, Listeria monocytogenes, has been very instructive in studying several facets of these phenomena
(26). This pathogen grows an F-actin "tail" or "comet" after
cellular entry, a phenomenon dependent on a surface protein, ActA (27).
ActA has an N-terminal domain that interacts with the Arp2/3 complex
(28, 29) followed by a proline-rich domain that interacts with Ena/VASP
family proteins (30). The Ena/VASP proteins, in turn, recruit actin
monomers bound to profilin and accelerate actin polymerization (31).
The organization of F-actin induced by ActA is strikingly similar to
the actin cytoskeletal organization that occurs at the leading edge of
lamellipodia in normal cells. Several human proteins have properties
similar to ActA. The zyxin family proteins that include zyxin (32),
LIM-containing lipoma-preferred partner (LPP) (33), and the trip6
protein (thyroid receptor-interacting protein-6) (34) have N-terminal
proline-rich domains that contain the same (F/L)PPPP motifs present in
ActA, and these proteins can bind to Ena/VASP proteins. The VCA
(Verprolin homology, Cofilin homology,
Acidic) domain of the WASp (Wiscott-Aldrich syndrome
protein) family is similar to the N-terminal domain of ActA and can
interact with Arp2/3 (35). It was reported recently that VASP binds
WASp directly in vitro, an interaction that may be essential
in stimulating actin assembly and membrane protrusion at the leading
edge (36). The zyxin, VASP, and WASp family proteins are all found at
sites of cell adhesion and in lamellipodia.
LIM domains were first identified in three transcription factors,
lin-11, isl-1, and mec-3, but have
since been identified in many other proteins including the paxillin and
zyxin families, LIM kinases, and LIM-containing transcription factors
(37, 38). The LIM domain is a cysteine- and histidine-rich,
zinc-coordinating domain and functions in mammalian cells as a
protein-protein interaction motif and probably as a DNA binding motif
as well. Proteins containing LIM domains may play important roles in a
variety of biological processes including cytoskeleton organization,
cell development, and signaling (38). The LIM domains of paxillin bind
to protein tyrosine phosphatase-PEST and support the function of
this molecule at focal adhesions (39). Paxillin also binds to
In this study, we have identified a new FLNB-binding protein, FBLP-1,
that contains both a proline-rich domain and LIM domains. Unlike
several other LIM family members we have tested, FBLP-1 has the ability
to bind to FLNB and to induce stress fiber formation. Thus, FBLP-1 may
play a role in the dynamic organization of stress fibers and perhaps of
other aspects of the cytoskeleton. The role of its LIM domains in this
activity remains to be explored. Furthermore, it is possible that
through its proline-rich domain, FBLP-1 may interact with Ena/VASP
family members and, thus, may provide a link between filamins and the
Arp2/3 complex. Studies to examine this possibility are currently underway.
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-pleated sheet homologous repeats
(1-3). In addition, each FLN contains two intercalated 24-36 residue
"hinge" regions, the first between repeats 15 and 16 and the second
between repeats 23 and 24. FLNs self-associate to form homodimers, an
interaction that requires the presence of repeat 24.
-integrins (7, 8), GpIb
(9), and tissue factor (10),
suggesting that they play a role in cytoskeletal-membrane interactions.
3) They associate with several cytoplasmic components of signaling
pathways including Rho GTPases (11), TRAF2 (12), Smads (13), and SEK-1
(14) and thus may serve as a scaffolding or point of convergence
for signals between the cell membrane and the cell interior.
Nevertheless, a clear mechanistic explanation for their importance is
still lacking.
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
/Leu
/His
/Ade
plates and incubated at 30 °C until colonies appeared. These colonies were re-streaked on plates containing X-
-gal to determine
-galactosidase activity of individual colonies. To exclude false positives, positive clones were re-introduced into yeast together with
either the FLNB-(10-18) vector or pLAM5', a vector encoding a human
lamin cDNA in the two-hybrid DNA-binding domain vector pGBKT7.
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
View larger version (51K):
[in a new window]
Fig. 1.
Nucleotide and deduced amino acid sequences
of human FBLP-1 cDNA. Nucleotide numbers and amino acid
numbers are indicated above the sequence (nucleotide/amino acid). The
in-frame stop codon in the 5'-upstream sequence is
underlined. Two LPPPP amino acid repeats are
boxed. The nuclear export signal sequence is indicated by a
double underline. The sequence of FBLP-1 3' to the
open arrowhead is spliced out and connected to the sequence
shown below in both FBLP-1A and FBLP-1B. The sequence demarcated by the
two black arrows is spliced out in FBLP-1B.
View larger version (12K):
[in a new window]
Fig. 2.
Structural comparison of FBLP-1 and several
homologous human proteins. The total amino acid number for each
protein is shown on the right.
View larger version (18K):
[in a new window]
Fig. 3.
Genomic structure of FBLP-1 and alternative
splicing patterns. The exonic structure of the FBLP-1
gene was determined according to a genomic DNA sequence
(GenBankTM accession number AL450998) from bacterial
contigs of human chromosome 1. Exons and introns are indicated as
boxes and lines, respectively.
View larger version (43K):
[in a new window]
Fig. 4.
Co-immunoprecipitation of FLNB and
FBLP-1. Immunoprecipitation was performed using anti-GFP antibody.
Lanes 1 and 2 are precipitated samples.
Lanes 3 and 4 are supernatants after
precipitations. Lanes 1 and 3 are from cells
transfected with constructs of full-length FLNB and GFP. Lanes
2 and 4 are from cells transfected with full-length
FLNB and GFP-FBLP-1. The upper and lower panels
were developed with anti-FLNB and anti-GFP, respectively.
-gal assays were performed. As shown in Fig.
5A, only constructs 1 and 2 interacted specifically with FPC1-22. This result indicates that
FBLP-1 binds to FLNB between repeats 10 and 13.
View larger version (25K):
[in a new window]
Fig. 5.
Yeast two-hybrid localization of the
interaction of FLNB and FBLP-1. A, the FLNB repeats are
numbered, and the hinges are shown in gray. The
FLNB deletion constructs are indicated below, and results of the
interaction with full-length FBLP-1 are shown to their
right. B, FBLP-1 variants and deletion mutants
are as indicated. Results of their interaction with FLNB-(10-18) are
shown on the right.
-gal
assay. As these transformed yeast grow slowly even on
Trp
/Leu
plates, it is possible that the
third LIM domain present in these two variants reduces the yeast growth rate.
View larger version (20K):
[in a new window]
Fig. 6.
Reverse transcriptase-PCR analysis of
FBLP-1 variants in human tissues. The upper panels
indicate amplification results for FBLP-1. The lower panels
show results for FBLP-1A and FBLP-1B. The amplification products of
human tissues (left panels) were stained with ethidium
bromide. The products of CMK and platelets (right panels)
were probed by Southern blot, because these signals were very faint by
ethidium bromide staining.
View larger version (35K):
[in a new window]
Fig. 7.
Cellular localization of FBLP-1 and filamins
in 293A cells. GFP-FBLP-1 (A-H) or GFP alone
(I and J) were transiently transfected into 293A
cells. GFP signal (A, D, G, and
I), anti-FLNB staining (B and J),
anti-FLNA staining (E), and phalloidin staining
(H) were analyzed by immunofluorescence microscopy. Cells
were plated on plastic culture dishes without gelatin coating.
Panels C and F are merged images of
panels A and B and panels D and
E, respectively.
View larger version (69K):
[in a new window]
Fig. 8.
Localization of FBLP-1 and zyxin in 293A
cells. GFP-FBLP-1 (A and C) or GFP-zyxin
(B and D) was transfected into 293A cells
cultured on gelatin-coated dishes. GFP signal (A and
B) and phalloidin staining (C and D)
were analyzed by indirect immunofluorescence microscopy. Panels
E and F are merged images of panels A and
C and panels B and D, respectively.
Solid arrowheads indicate filopodia, and open
arrowheads indicate lamellipodia.
View larger version (42K):
[in a new window]
Fig. 9.
Localization of FBLP-1 and vinculin in 293A
cells. 293A cells cultured on gelatin-coated plates were
transfected with GFP-FBLP-1. All of the images are of the same
transfected cell. Lower images are higher magnification
views of upper images. FBLP-1 was detected as GFP signal
(green), and vinculin was detected by anti-vinculin antibody
(red).
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1A and
1D at the tips of stress fibers, suggesting that
filamins interact with these proteins and may organize actin filaments
depending on the state of cell activation. However, a large body of
recent literature concludes that the Arp2/3 complex has a predominant
intracellular role in promoting the formation of orthogonal actin
networks, at least at the leading edge of the cell (22), and that an
actin filament network, which resembles closely that seen in cells, can
be produced in cell-free systems in the absence of filamins
(23). In Drosophila, the Arp2/3 complex is required for specific
subsets of actin polymerization events (e.g. ring canal
formation during oogenesis); however, the formation of parallel actin
bundles apparently does not depend on Arp2/3 function (24). From study
of the Drosophila cheerio mutant, the suggestion has been
made that a branching F-actin network may be transformed into parallel
bundles through the action of filamin, the product of the
cheerio gene (25). Because both the Arp2/3 complex and
filamins localize in sites of actin reorganization (22), it is possible
that the Arp2/3 complex synergizes in some manner with one or more of
the filamins.
-tubulin and may facilitate cross-talk between actin filaments and
microtubules (40). Hic-5 has been reported to bind to DNA in a
zinc-dependent manner through its LIM domains and may
regulate transcription of several proteins (38).
![]() |
ACKNOWLEDGEMENT |
---|
We thank Andrew Likens for expert assistance with the graphics.
![]() |
FOOTNOTES |
---|
* This work was supported in part by Grant HL09163 from the National Institutes of Health (to S. S. S.) and by grants from the Delaware Valley and Brandywine Valley Hemophilia Foundations (to T. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Both authors contributed equally to this work.
** To whom correspondence should be addressed. Tel.: 215-955-2070; Fax: 215-955-2101; E-mail: Sandor.Shapiro@mail.tju.edu.
Published, JBC Papers in Press, December 20, 2002, DOI 10.1074/jbc.M209339200
![]() |
ABBREVIATIONS |
---|
The abbreviations used are:
FLN, filamin;
FBLP-1, filamin-binding LIM protein-1;
X--gal, 5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside;
RACE, rapid amplification of cDNA ends;
GFP, green fluorescent protein;
TRITC, tetramethylrhodamine isothiocyanate;
LPP, LIM- containing
lipoma-preferred partner;
VASP, vasodilator-stimulated
phosphoprotein.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Shapiro, S. S., and Takafuta, T. (2001) in Encyclopedia of Molecular Medicine (Creighton, T. E., ed), Vol. 2 , pp. 1289-1291, John Wiley & Sons, Inc., New York |
2. | Stossel, T. P., Condeelis, J., Cooley, L., Hartwig, J. H., Noegel, A., Schleicher, M., and Shapiro, S. S. (2001) Nat. Rev. Mol. Cell. Biol. 2, 138-145[CrossRef][Medline] [Order article via Infotrieve] |
3. | van der Flier, A., and Sonnenberg, A. (2001) Biochim. Biophys. Acta 1538, 99-117[Medline] [Order article via Infotrieve] |
4. | Weihing, R. R. (1985) Can. J. Biochem. Cell Biol. 63, 397-413[Medline] [Order article via Infotrieve] |
5. | Hartwig, J. H., Tyler, J., and Stossel, T. P. (1980) J. Cell Biol. 87, 841-848[Abstract] |
6. | Cunningham, C. C., Gorlin, J. B., Kwiatkowski, D. J., Hartwig, J. H., Janmey, P. A., Byers, H. R., and Stossel, T. P. (1992) Science 255, 325-327[Medline] [Order article via Infotrieve] |
7. |
Loo, D. T.,
Kanner, S. B.,
and Aruffo, A.
(1998)
J. Biol. Chem.
273,
23304-23312 |
8. |
van der Flier, A.,
Kuikman, I.,
Kramer, D.,
Geerts, D.,
Kreft, M.,
Takafuta, T.,
Shapiro, S. S.,
and Sonnenberg, A.
(2002)
J. Cell Biol.
156,
361-376 |
9. |
Takafuta, T.,
Wu, G.,
Murphy, G. F.,
and Shapiro, S. S.
(1998)
J. Biol. Chem.
273,
17531-17538 |
10. |
Ott, I.,
Fischer, E. G.,
Miyagi, Y.,
Mueller, B. M.,
and Ruf, W.
(1998)
J. Cell Biol.
140,
1241-1253 |
11. |
Ohta, Y.,
Suzuki, N.,
Nakamura, S.,
Hartwig, J. H.,
and Stossel, T. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2122-2128 |
12. |
Leonardi, A.,
Ellinger-Ziegelbauer, H.,
Franzoso, G.,
Brown, K.,
and Siebenlist, U.
(2000)
J. Biol. Chem.
275,
271-278 |
13. |
Sasaki, A.,
Masuda, Y.,
Ohta, Y.,
Ikeda, K.,
and Watanabe, K.
(2001)
J. Biol. Chem.
276,
17871-17877 |
14. |
Marti, A.,
Luo, Z.,
Cunningham, C.,
Ohta, Y.,
Hartwig, J.,
Stossel, T. P.,
Kyriakis, J. M.,
and Avruch, J.
(1997)
J. Biol. Chem.
272,
2620-2628 |
15. |
Yuan, Y.,
and Shen, Z.
(2001)
J. Biol. Chem.
276,
48318-48324 |
16. |
Nikki, M.,
Merilainen, J.,
and Lehto, V. P.
(2002)
J. Biol. Chem.
277,
11432-11440 |
17. |
Awata, H.,
Huang, C.,
Handlogten, M. E.,
and Miller, R. T.
(2001)
J. Biol. Chem.
276,
34871-34879 |
18. | Nagano, T., Yoneda, T., Hatanaka, Y., Kubota, C., Murakami, F., and Sato, M. (2002) Nat. Cell Biol. 4, 495-501[CrossRef][Medline] [Order article via Infotrieve] |
19. |
Dyson, J. M.,
O'Malley, C. J.,
Becanovic, J.,
Munday, A. D.,
Berndt, M. C.,
Coghill, I. D.,
Nandurkar, H. H.,
Ooms, L. M.,
and Mitchell, C. A.
(2001)
J. Cell Biol.
155,
1065-1079 |
20. |
Barry, C. P.,
Xie, J.,
Lemmon, V.,
and Young, A. P.
(1993)
J. Biol. Chem.
268,
25577-25586 |
21. |
Flanagan, L. A.,
Chou, J.,
Falet, H.,
Neujahr, R.,
Hartwig, J. H.,
and Stossel, T. P.
(2001)
J. Cell Biol.
155,
511-517 |
22. |
Svitkina, T. M.,
and Borisy, G. G.
(1999)
J. Cell Biol.
145,
1009-1026 |
23. | Cameron, L. A., Svitkina, T. M., Vignjevic, D., Theriot, J. A., and Borisy, G. G. (2001) Curr. Biol. 11, 130-135[CrossRef][Medline] [Order article via Infotrieve] |
24. |
Hudson, A. M.,
and Cooley, L.
(2002)
J. Cell Biol.
156,
677-687 |
25. | Sokol, N. S., and Cooley, L. (1999) Curr. Biol. 9, 1221-1230[CrossRef][Medline] [Order article via Infotrieve] |
26. | Beckerle, M. C. (1998) Cell 95, 741-748[Medline] [Order article via Infotrieve] |
27. | Pistor, S., Chakraborty, T., Niebuhr, K., Domann, E., and Wehland, J. (1994) EMBO J. 13, 758-763[Abstract] |
28. | Welch, M. D., Iwamatsu, A., and Mitchison, T. J. (1997) Nature 385, 265-269[CrossRef][Medline] [Order article via Infotrieve] |
29. |
Zalevsky, J.,
Grigorova, I.,
and Mullins, R. D.
(2001)
J. Biol. Chem.
276,
3468-3475 |
30. |
Niebuhr, K.,
Ebel, F.,
Frank, R.,
Reinhard, M.,
Domann, E.,
Carl, U. D.,
Walter, U.,
Gertler, F. B.,
Wehland, J.,
and Chakraborty, T.
(1997)
EMBO J.
16,
5433-5444 |
31. |
Machner, M. P.,
Urbanke, C.,
Barzik, M.,
Otten, S.,
Sechi, A. S.,
Wehland, J.,
and Heinz, D. W.
(2001)
J. Biol. Chem.
276,
40096-40103 |
32. |
Golsteyn, R. M.,
Beckerle, M. C.,
Koay, T.,
and Friederich, E.
(1997)
J. Cell Sci.
110,
1893-1906 |
33. |
Petit, M. M.,
Fradelizi, J.,
Golsteyn, R. M.,
Ayoubi, T. A.,
Menichi, B.,
Louvard, D.,
Van de Ven, W. J.,
and Friederich, E.
(2000)
Mol. Biol. Cell
11,
117-129 |
34. | Wang, Y., and Gilmore, T. D. (2001) Biochim. Biophys. Acta 1538, 260-272[CrossRef][Medline] [Order article via Infotrieve] |
35. |
Higgs, H. N.,
and Pollard, T. D.
(1999)
J. Biol. Chem.
274,
32531-32534 |
36. |
Castellano, F.,
Le Clainche, C.,
Patin, D.,
Carlier, M. F.,
and Chavrier, P.
(2001)
EMBO J.
20,
5603-5614 |
37. | Turner, C. E. (2000) Nat. Cell Biol. 2, E231-236[CrossRef][Medline] [Order article via Infotrieve] |
38. | Bach, I. (2000) Mech. Dev. 91, 5-17[CrossRef][Medline] [Order article via Infotrieve] |
39. |
Shen, Y.,
Schneider, G.,
Cloutier, J. F.,
Veillette, A.,
and Schaller, M. D.
(1998)
J. Biol. Chem.
273,
6474-6481 |
40. |
Herreros, L.,
Rodriguez-Fernandez, J. L.,
Brown, M. C.,
Alonso-Lebrero, J. L.,
Cabanas, C.,
Sanchez-Madrid, F.,
Longo, N.,
Turner, C. E.,
and Sanchez-Mateos, P.
(2000)
J. Biol. Chem.
275,
26436-26440 |